StockData
CervoMed Inc. logo

CervoMed Inc. (CRVO) stock

CRVONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 5/30
$1.50−0.17 (-10.18%)

Close on Nov 17, 2026Market cap $22.68MP/E –Yield –

CervoMed enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

CervoMed's enterprise value was -$958.57K on Nov 11, 2026, against $64.67M a year earlier. Over the last 5 years it ranged from -$28.00M to $2.33B, with a median of $16.02M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026-$958.57K-102.1%
2025Dec 31, 2025$45.80M–
2024Dec 31, 2024-$27.34M-183.2%
2023Dec 29, 2023$32.87M–
2022Dec 30, 2022-$8.59M-100.4%
2021Dec 31, 2021$2.33B-39.0%
2020Dec 31, 2020$3.82B+2347.7%
2019Dec 31, 2019$156.02M-68.3%
2018Dec 31, 2018$492.17M-61.6%
2017Dec 29, 2017$1.28B-26.7%
2016Dec 30, 2016$1.75B+25.6%
2015Dec 31, 2015$1.39B-69.4%
2014Dec 31, 2014$4.56B+381.2%
2013Dec 31, 2013$946.86M-26.4%
2012Dec 31, 2012$1.29B-55.9%
2011Dec 30, 2011$2.92B–

More CervoMed figures

See a number that looks wrong?